All In Biotech

Drug Trial Radar · NCT07076407

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)

A Phase 3, Randomized, Double-blind, Placebo-Controlled, Multicenter Study to Evaluate Azetukalner in Moderate-to-Severe Major Depressive Disorder

Last checked: Nov 19, 2026Latest source record: Oct 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 450 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

450

Planned (sponsor's estimate)

Start

Jul 8, 2025

Primary completion

May 2027

Study completion Jul 2027

Sponsor

Lead sponsor
Xenon Pharmaceuticals Inc.Industry
Sponsor type
Industry
First posted
Jul 22, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 74 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

X-NOVA3 is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of azetukalner as a monotherapy in adult participants diagnosed with Major Depressive Disorder (MDD)

Conditions

  • Major Depressive Disorder

Interventions

  • AzetukalnerDrug

    Azetukalner 20 mg taken orally once a day with food (with the evening meal when possible) for 6 weeks

  • PlaceboDrug

    Placebo taken orally once a day with food (with the evening meal when possible) for 6 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline in the Hamilton Depression Rating Scale, 17-item (HAMD-17) score at Week 6Time frame: Baseline to Week 6

Locations

50 sites in 7 countries. Site status is shown where the registry gives one.

  • Harmonex Neuroscience Research

    Dothan, Alabama

  • University of Alabama at Birmingham, Huntsville Regional Medical Campus

    Huntsville, Alabama

  • Pillar Clinical Research

    Bentonville, Arkansas

  • SanRo Clinical Research Group

    Bryant, Arkansas

  • Clinical Innovations Inc

    Bellflower, California

  • Center for Neurohealth

    La Jolla, California

  • Artemis Institute for Clinical Research

    San Diego, California

  • California Neuroscience Research

    Sherman Oaks, California

  • Pacific Clinical Research Management Group

    Upland, California

  • Institute of Living

    Hartford, Connecticut

  • Gulfcoast Clinical Research Center

    Fort Myers, Florida

  • Sarkis Clinical Trials

    Gainesville, Florida

  • Equipath Health and Research Tampa Bay, Llc

    Riverview, Florida

  • Delricht Research

    Atlanta, Georgia

  • Emory University Brain Health Center

    Atlanta, Georgia

  • Advanced Quality Medical Research

    Orland Park, Illinois

  • Smart Trials, LLC

    Jefferson, Louisiana

  • Pharmasite Research Inc.

    Baltimore, Maryland

  • Adams Clinical Boston

    Boston, Massachusetts

  • Activmed Practices & Research, Llc - Methuen

    Methuen, Massachusetts

  • Adams Clinical Watertown

    Watertown, Massachusetts

  • Vitalix Clinical, Inc

    Worcester, Massachusetts

  • Psychiatric Care and Research Center

    O'Fallon, Missouri

  • St. Charles Psychiatric Associates - Midwest Research Group

    Saint Charles, Missouri

  • Lumina Clinical Research Center

    Cherry Hill, New Jersey

  • Princeton Medical Institute

    Princeton, New Jersey

  • Bio Behavioral Health

    Toms River, New Jersey

  • Bioscience Research, LLC

    Mount Kisco, New York

  • Fieve Clinical Research, Inc.

    New York, New York

  • IMA Clinical Research

    New York, New York

  • Magnolia Clinical Research, Llc

    Cary, North Carolina

  • Insight Clinical Trials

    Independence, Ohio

  • Sooner Clinical Research

    Oklahoma City, Oklahoma

  • Austin Clinical Trial Partners

    Austin, Texas

  • Boeson Research

    Provo, Utah

  • Suomen Terveystalo Oy

    Helsinki, Finland

  • Oulu Mentalcare Oy

    Oulu, Finland

  • Charite - Universitatsmedizin Berline

    Berlin, Germany

  • Boehm-Peters PartGmbB - Praxis fur Psychiatrie, Psychotherapie, Neurologie

    Rosenheim, Germany

  • In Vivo Sp. z.o.o.

    Bydgoszcz, Poland

Showing 40 of 50 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.